| Symbol |
Name |
|
ABCA12
|
ATP-binding cassette, sub-family A (ABC1), member 12
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
BBS10
|
Bardet-Biedl syndrome 10
|
|
BBS12
|
Bardet-Biedl syndrome 12
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
|
EDN1
|
endothelin 1
|
|
EGR1
|
early growth response 1
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EP300
|
E1A binding protein p300
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FABP6
|
fatty acid binding protein 6, ileal
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
HILPDA
|
hypoxia inducible lipid droplet-associated
|
|
HIST2H2BE
|
histone cluster 2, H2be
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
IL10
|
interleukin 10
|
|
IL4
|
interleukin 4
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
IVL
|
involucrin
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KLF2
|
Kruppel-like factor 2
|
|
LANCL2
|
LanC lantibiotic synthetase component C-like 2 (bacterial)
|
|
LEP
|
leptin
|
|
LMO4
|
LIM domain only 4
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MECR
|
mitochondrial trans-2-enoyl-CoA reductase
|
|
MIR21
|
microRNA 21
|
|
MMP9
|
matrix metallopeptidase 9
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2C1
|
nuclear receptor subfamily 2, group C, member 1
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
PARG
|
poly (ADP-ribose) glycohydrolase
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PML
|
promyelocytic leukemia
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RETN
|
resistin
|
|
RXRA
|
retinoid X receptor, alpha
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TLL1
|
tolloid-like 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
